Scientific Program

  • WCLC 2020 - Virtual Presidential Symposium

    The International Association for the Study of Lung Cancer (IASLC) was presenting potentially practice-changing studies and recent advances in thoracic oncology at this IASLC WCLC 2020 Virtual Presidential Symposium. This Symposium is a prelude to the new innovative research that will be presented at WCLC 2020 scheduled for January 28-31, 2021.

    Presentation Date(s):  
    • August 8, 2020
    • Total Presentations: 9
Filter Results:

Show Only CME Accredited Sessions

  • +

    VPS2020 - WCLC 2020 - Virtual Presidential Symposium

    • 08:00 - 17:00
    • 8/19/2020
    • Location:
    • Type: Online Presentation
    • +

      Educational Talk 1 - Peri-operative Adjuvant IO or TKIs Therapy for Resected NSCLC

      11:15 - 11:25  |  Presenting Author(s): Masahiro Tsuboi

      • Abstract

      Abstract not provided

    • +

      Educational Talk 2 - COVID-19 in Thoracic Malignancies

      11:26 - 11:36  |  Presenting Author(s): Marina Garassino

      • Abstract

      Abstract not provided

    • +

      Educational Talk 3 - A Lung Cancer Patient's Manifesto for Modernizing Clinical Trials

      11:37 - 11:47  |  Presenting Author(s): Janet Freeman-Daily

      • Abstract

      Abstract not provided

    • +

      Abstract 1: ORIENT-11: Sintilimab + Pemetrexed + Platinum as First-Line Therapy for Locally Advanced or Metastatic Non-Squamous NSCLC

      11:49 - 11:59  |  Presenting Author(s): Li Zhang

      • Abstract

      Abstract not provided

    • +

      Discussant 1

      11:59 - 12:09  |  Presenting Author(s): Misako Nagasaka

      • Abstract

      Abstract not provided

    • +

      Abstract 2: Phase III Randomized Study of Ensartinib vs Crizotinib in Anaplastic Lymphoma Kinase (ALK) Positive NSCLC Patients: eXalt3

      12:11 - 12:21  |  Presenting Author(s): Leora Horn

      • Abstract

      Abstract not provided

    • +

      Discussant 2

      12:21 - 12:31  |  Presenting Author(s): Christine Lovly

      • Abstract

      Abstract not provided

    • +

      Abstract 3: First-line Nivolumab + Ipilimumab vs Chemotherapy in Unresectable Malignant Pleural Mesothelioma: CheckMate 743

      12:33 - 12:43  |  Presenting Author(s): Paul Baas

      • Abstract

      Abstract not provided

    • +

      Discussant 3

      12:43 - 12:53  |  Presenting Author(s): Dean Fennell

      • Abstract

      Abstract not provided

    • +

      Live Q&A with all Abstract Presenters and Discussants

      12:54 - 13:04  |  Presenting Author(s): Murry Wynes, Chandra Belani

      • Abstract

      Abstract not provided